Sandesh Mahatme - 30 May 2024 Form 3 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Director
Signature
/s/ Sandesh Mahatme
Issuer symbol
CRSP
Transactions as of
30 May 2024
Net transactions value
$0
Form type
3
Filing time
30 May 2024, 16:27:55 UTC
Previous filing
09 Jun 2022
Next filing
06 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRSP Stock Option (Right to Buy) 30 May 2024 Common Shares 26,000 $44.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on October 16, 2023 with respect to 26,000 Common Shares. 100% of the shares will vest in 36 equal monthly installments, with the first vesting date of November 16, 2023.

Remarks:

Exhibit 24 - Power of Attorney